Effect of Spring Gravity Bar on Gait Pattern in Children With Spastic Diplegia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04628247 |
|
Recruitment Status :
Recruiting
First Posted : November 13, 2020
Last Update Posted : November 13, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Spastic Diplegia Cerebral Palsy | Device: Spring gravity bar | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 20 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Effect of Spring Gravity Bar on Gait Pattern in Children With Spastic Diplegia |
| Actual Study Start Date : | September 21, 2020 |
| Estimated Primary Completion Date : | November 2020 |
| Estimated Study Completion Date : | December 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Study group
They will receive the same traditional physical therapy exercise program in addition to gait training on spring gravity bar for one hour
|
Device: Spring gravity bar
|
- Two dimensional gait analysis [ Time Frame: 20 minute ]Two-dimensional (2D) video analysis may provide an accessible and affordable means of quantifying postural control deficits that can be implemented across a spectrum of care settings. Angular joint measures during weight lifting obtained using 2D motion analysis software have been shown to be highly correlated to goniometric measures . This system has also been shown to be reliable in quantifying range of motion during reaching and walking/running tasks
- Dynamic gait index [ Time Frame: 20 minute ]The Dynamic Gait Index is a sensitive and efficient tool for adults and therefore may be a useful tool for children. Dynamic Gait Index (DGI) is a performance-based tool that quantifiesthe dynamic balance instability developed by Shumway-Cook and Woollacott, evaluates the ability of the individual to modify gait in response to changing functions during walking
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 7 Years to 10 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Their age will be extended from 7 to 10 years.
- They can walk with limitation or holding on according to GMFCS (level II & II).
- They can understand and follow instruction.
Exclusion Criteria:
- 1-children with any visual or auditory abnormalities. 2-children receiving any special medication affecting muscle and /or mental function.
3-children had any recent surgical interference in the lower limb. 4-children with perceptual defects. 5-children with fixed structural deformities lower limb.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04628247
| Contact: Baseem Zaki Mahmoud, BSc physiotherapy | 002001553896691 | baseem2022@googlemail.com | |
| Contact: Nahla Mohamed Ibrahium, Lecture | 002001001937744 | Nahlahegazy1983@googlemail.com |
| Egypt | |
| Cairo University Pediatric Hospital | Recruiting |
| Cairo, Egypt | |
| Responsible Party: | Baseem Zaki Mahmoud, BSc physiotherapy, Cairo University |
| ClinicalTrials.gov Identifier: | NCT04628247 |
| Other Study ID Numbers: |
P.T.REC/012/002557 |
| First Posted: | November 13, 2020 Key Record Dates |
| Last Update Posted: | November 13, 2020 |
| Last Verified: | November 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Muscle Spasticity Cerebral Palsy Brain Damage, Chronic Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Muscular Diseases Musculoskeletal Diseases Muscle Hypertonia Neuromuscular Manifestations Neurologic Manifestations |

